1 Min Read
April 20 (Reuters) - Prometic Life Sciences Inc:
* Prometic’s PBI-4050 shown to reduce liver damage and fibrosis in high-fat diet induced obesity and metabolic syndrome mouse model Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.